|
| Clinical Research of Anxinlü Capsule on Controlling Premature Beating in Children Persisting Myocarditis |
| Hits 1510 Download times 1817 Received:March 26, 2002 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2002.04.10 |
| Key Words
Anxinlü Capsule;premature beating;children persisting myocarditis;TCM and Chinese materia medica |
| Author Name | Affiliation | | Qiao Weiping | The First Affliated Hospital to Tianjin University of TCM, Tianjin 300193, China | | Yin Chengwang | The First Affliated Hospital to Tianjin University of TCM, Tianjin 300193, China | | Xing Yanwei | The First Affliated Hospital to Tianjin University of TCM, Tianjin 300193, China | | 胡思源 | The First Affliated Hospital to Tianjin University of TCM, Tianjin 300193, China |
|
| Abstract
|
| Objective: To test and verify the effect of Anxinlü Capsule, a compound preparation of Chinese materia medica, on controlling premature beating and thereby to replenish its therapeutic scheme.Methods: Children with refractory persisting myocarditis and premature beating were enrolled in this clinical trial.They were studied with the fashion of random division (1:1) and parallel control.The therapeutic scheme for persisting myocarditis and Anxinlü Capsule were given in treatment group, whereas only the scheme in control group.The effects on controlling premature beating were evaluated and the occurrences of side effect were observed. Results: After 6 to 12 months, the curative rate of premature beating was 51.61% and the total effective rate 90.32% in the treatment group. They were higher than those in the control group (P<0.05).The total effective rate for treating persisting myocarditis in treatment group (96.77%) was also higher than in control group. Conclusion: Anxinlü Capsule has a certain effect on controlling premature beating. The clinical effect of this capsule for treating children persisting myocarditis complicated with premature beating can be enhanced correspondingly. |
|
